Singapore legislation

Regulation 23

of Health Products (Clinical Trials) Regulations 2016

Regulation 23

Record of clinical trials

Amended byS 107/2021 wef 01/03/2021S 107/2021 wef 01/03/2021S 107/2021 wef 01/03/2021S 107/2021 wef 01/03/2021S 107/2021 wef 01/03/2021

Subregulation 1

Amended byS 107/2021 wef 01/03/2021S 107/2021 wef 01/03/2021S 107/2021 wef 01/03/2021

The sponsor and a principal investigator must keep such records of the clinical trial, in accordance with paragraph (2), as will individually and collectively —

(a)

permit proper evaluations to be made of the conduct of the trial and the quality of the data produced;

(b)

demonstrate compliance by each person involved in the trial with the principles of good clinical practice and all applicable regulatory requirements; and

(c)

in the case of an investigational product that is an applicable CTGT product, allow traceability of the product.

Subregulation 2

Amended byS 107/2021 wef 01/03/2021S 107/2021 wef 01/03/2021

The records mentioned in paragraph (1) must —

(a)

be kept up‑to‑date at all times;

(b)

be available at all times for inspection by the Authority or any person authorised by the Authority in that behalf; and

(c)

be kept at least until the later or the latest, as the case may be, of the following:

(i)

the date where there is no more pending or contemplated application for registration under the Act of the therapeutic product or applicable CTGT product being tested in the clinical trial;

(ii)

the expiry of 2 years after the last of such registrations is granted;

(iii)

where the clinical trial is terminated, the expiry of 2 years after the Authority has been informed of the termination of the trial under regulation 12;

(iv)

the expiry of 6 years after the conclusion of the clinical trial;

(iva)where the record is of a clinical trial that involves an applicable CTGT product and relates to the traceability of that product — the expiry of 30 years after the expiry date of that product or any other shorter period that the Authority allows in a particular case;

(v)

the expiry of such other period as the Authority may direct in any particular case.

Subregulation 3

Without limiting the generality of paragraph (1), the principal investigator must maintain a record of every person assisting the principal investigator in the clinical trial, containing all of the following information:

(a)

the person’s name;

(b)

the person’s qualifications;

(c)

the person’s responsibilities in the trial.